NNN member Smartfish is a company developing omega-3 based pharmaconutrition products. A study presented at the Alzheimer’s Association International Conference in Boston in July, could potentially link a Smartfish drink to prevention of Alzheimer’s disease. 

Behind the international consensus on EEG interpretation published in Epilepsia this summer, is the system developed and marketed by NNN member company Holberg EEG. 

NNN are currently working to create an overview of dementia-related medical research and development in Norway. This report will be presented at our national symposium in Oslo. 

DiaGenic announced this summer that the validation study for their blood based diagnostic test for Alzheimer's disease in the pre-dementia stage, had failed to reach the study goals.

Professor Tormod Fladby was voted for the NNN Board at last week’s general assembly.

Judith J. W. Wong is joining Nansen Neuroscience as a communication associate. Judith studies pharmacy at the University of Oslo (UiO) and is a third-year student this fall. 

Last week, NNN hosted a meeting where researchers, clinicians and industry met to discuss national harmonization of brain MR protocols.

NNN to host National symposia on October 22nd and November 20th.